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Abstract
BACKGROUND: The incidence and survival rates of cerebral tumor patients are increasing, along with advances in 
medical technology. Severe complications, such as multiorgan failure in patients, cause the need for intensive care to 
improve. The effectiveness of intensive care in tumor patients is still controversial, considering that patients included 
in low and vulnerable performance status. Patients with cerebral tumors also require intensive care either before 
or after effective action. The controversy of economic and ethical issues still places aggressive action in intensive 
care on oncology patients. It is necessary to identify and know the characteristics of tumor patients that are useful 
in intensive management.
AIM: The purpose of this study was to determine the demographic characteristics, length of stay, complications, 
and mortality rates of cerebral tumor patients undergoing intensive care at Sanglah Hospital Denpasar, the period 
January–December 2017.
METHODS: This study is a cross-sectional descriptive where all sample data collection is secondarily based on 
existing medical records. The sample population in this study were cerebral tumor patients treated in the intensive 
care ward Sanglah period January–December 2017 who met the inclusion criteria.
RESULTS: In the study, it found that 54 patients with the highest number of cerebral tumors treated in the intense 
sex with women (64.85%) and middle-aged adults (41–60 years) were 31 patients (57.4%). Most diagnoses of 
cerebral tumors were 39 non-glioma tumors (72.2%) followed by glioma tumors (20.4%) and tumor metastases 
(7.4%). Non-glioma tumors noted were meningiomas of around 48.1%, followed by glioblastoma multiforme tumors 
of 9.3%, tumors at the cerebellopontine angle and tumor metastases of 7.4%, respectively. All patients were treated 
intensively after receiving surgical therapy with a Karnofsky 50 score of about 29 patients (53.7%). All patients came 
out alive, and there were no recorded complications during treatment with the maximum length of stay of patients in 
the intensive care unit for up to 3 days by 45 patients (83.3%).
CONCLUSION: The most brain tumor cases are meningioma, which occurred in women, middle-aged adults with no 
mortality and complications within 3 days during treatment intensive care.
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Introduction
Cerebral tumors or brain tumors are one 
part of malignant disease, which is increasing in 
number along with advances in medical technology 
in terms of diagnosis. The survival rate in patients 
with cerebral tumors is felt to be increasingly long 
with emerging supportive and anti-tumor therapies. 
Causes the problems and complications faced by 
tumor patients, especially cerebral tumors, and more 
and more with the need for intensive space also 
increasing.
The effectiveness of intensive care in tumor 
or cancer patients is still controversial. Patients with 
tumors themselves belong to the category of patients 
with low and vulnerable performance status [1]. Patients 
with cancer have lower survival rates compared to 
patients without comorbidities. The mortality rate is 
also more economical when compared to patients with 
critical illnesses such as heart failure, liver cirrhosis, or 
other serious chronic diseases [2]. However, severe 
complications still cause multiorgan failure in patients 
with tumors.
The entry of tumor patients into intensive space 
has increased around the past two decades, around 
10–20% of all patients in intense. Intensivists deal 
more with tumor patients with dysfunction of organs 
that enter the fierce, especially the failure of respiratory 
function, infection, fatal complications, or toxins [2]. 
About 71 patients with cerebral tumors come the 
intensive care unit due to refractory seizures (41%) and 
septic shock (17%) [3]. Patients with cerebral tumors 
also require intensive care before surgery or after the 
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procedure. Management of post-operative patients in 
intensive care causes us to detect rapid neurological 
deterioration and maintain neurological and systemic 
homeostasis [4]. The prognosis of patients with cerebral 
tumors in great space is usually relatively poor. The 
controversy of economic and ethical issues still places 
aggressive action in intensive care on patients with 
oncology, identifying patients that are useful in critical 
intensive care before entering patients into intensive 
care [3].
Methods
This study is a cross-sectional observational 
study in which all data collection research samples 
are secondary based on existing medical records. The 
sample population in this study were cerebral tumor 
patients who were treated in the intensive care unit at 
Sanglah General Hospital from January to December 
2017 that met the inclusion criteria. Inclusion criteria 
are patients who have a complete medical record. The 
sampling technique was carried out by following the 
type nonrandom sampling method, where all medical 
records that met the eligibility criteria included as the 
study sample.
Results
There were 54 samples of patients with 
cerebral tumors included in this study. The following is 
a table of the essential characteristics of tumor patients 
in intensive space.
The primary characteristics of the study 
sample based on age, gender, level of education, 
and occupation shown in Table 1. Table 1 known that 
cerebral tumor patients treated in intensive space 
during 2017 were more female (64.85%) with the age 
of most middle-aged adults (41–60 years) as many 
as 31 patients (57.4%) and age early adults (18–40 
years) around 16 patients (29.6%). The work of most 
patients does not work, including homemakers, about 
22 patients (40.7%), with an average education level of 
fewer than 9 years around 50% or 27 patients followed 
by education levels above 9 years around 24 patients 
(44.4 %).
Based on Table 2, it found that most patients 
with cerebral tumors included 39 non-glioma tumors 
(72.2%) followed by glioma tumors (20.4%) and tumor 
metastases (7.4%). All patients or 100% received a 
history of surgical therapy with a Karnofsky 50 score 
of around 29 cerebral tumor patients (53.7%), a score 
of 40 as many as 20 patients (37%). Patients with 
intensive cerebral tumors treated with ventilators were 
29 patients (53.7%) and without ventilators, around 
25 patients (46.3%), where the conditions of absolute 
discharge were all alive, and no complications noted 
during treatment. The length of stay for patients in 
intensive care up to 3 days was 45 patients (83.3%) 
and nine patients more than 3 days (16.7%).
Table 1: Characteristics of cerebri tumor patients in the 
intensive care unit of Sanglah General Hospital in 2017
Variable Respondents (%)
Gender
Male 19 (35.2)
Female 35 (64.85)
Age 
Teenager 3 (5.6)
Young adult 16 (29.6)
Middle adulthood 31 (57.4)
Old adult 4 (7.4)
Education
Uneducation 3 (5.6)
<9 years 27 (50)
>9 years 24 (44.4)
Occupation
Unemployment 22 (40.7)
Civil servant 9 (16.7)
Entrepreneur 10 (18.5)
Farmer 9 (16.7)
Etc. 4 (7.4)
Table 2: Clinical characteristics of cerebral tumor patients in 
the intensive care unit of Sanglah General Hospital in 2017
Variable Respondents (%)
Diagnosis 
Glioma 11 (20.4)
Non-glioma 39 (72.2)
Metastases 4 (7.4)
Therapy 
Surgery 54 (100)
Non-surgery 0 (0)
Karnofsky score
30 2 (3.7)
40 20 (37)
50 29 (53.7)
60 3 (5.6)
Ventilator support
Yes 29 (53.7)
No 25 (46.3)
Length of stay
≤3 days 45 (83.3)
>3 days 9 (16.7)
Outcome
Life 54 (100)
Death 0 (0)
Complication 
Yes 0 (0)
No 54 (100)
The most frequently diagnosed cerebral tumor 
in the intensive care unit in 2017 according to Table 3 is 
non-glioma tumors, namely, meningioma, about 
Table 3: Diagnosis of cerebral tumors in the intensive care unit 
of Sanglah General Hospital in 2017
Variable Respondents (%)
Diagnosis
Meningioma 26 (48.1)
Astrocytoma 2 (3.7)
Glioblastoma multiforme 5 (9.3)
Ependymoma 1 (1.9)
Adenoma hipofisis 2 (3.7)
Cerebellopontine angle tumor 4 (7.5)
Medulloblastoma 2 (3.7)
Non-Hodgkin lymphoma 1 (1.9)
Oligodendroglioma 3 (5.6)
Brain metastases 4 (7.4)
Cerebellum tumor 2 (3.7)
Sarcoma 2 (3.7)
48.1%, followed by glioblastoma multiforme tumors 
in 5 patients (9.3%), tumors at the cerebellopontine 
angle and tumor metastases, respectively, 4 patients 
(7.4%).
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Discussion
Based on the results of the research data, it 
found that patients treated in intensive spaces during 
2017 were mostly in middle adulthood, which was 
around 41–60 years old. This is following with a research 
by Oemiati et al. (2011) where the age increases, the 
risk of developing a cerebral tumor is higher which 
reaches its peak around the age of 35–44 years [5]. 
Epidemiological studies in Iran get the most cases of 
cerebral tumors at the age of 40 years ± 19.8 years [6].
Female sex obtained more than men [7]. 
The process of cAMP synthesis and degradation is 
different in male and female astrocytic cells for basal 
cAMP levels [8]. In the animal model, mice found that 
low cAMP levels supporting the development of tumor 
cells and drugs that increase cAMP such as rolipram 
have strong anti-tumor [9], [10], [11], levels were 
tumorigenesis regulators in neurofibromatosis type 
1 (NF1) in optical gliomas [12]. Polymorphism in the 
adenylate cyclase eight gene correlates with the risk 
of glioma in NF1, increasing in women, and reducing 
risk in men [8]. Female patients were predominant than 
males with a ratio of 1.8:1, resembling of those found in 
South Korea study [13]. The Department of Neurology 
at Cipto Mangunkusumo Hospital in 2011–2015 
obtained an average age of 48 patients (18–74 years) 
with a higher proportion of women than men (55.6% 
compared to 44.4%). This is slightly different from that 
reported by McKinney (2004), where it said that male 
more often diagnosed with cerebral tumors than women 
with a ratio of 1.5:1 [14]. However, it also explained 
that women suffer from meningioma more than men. 
Increased risk of meningioma in women is related to 
the presence of estrogen, progesterone, and androgen 
receptors in some types of meningioma. Changes in 
the size and volume of meningiomas sharply increase 
in the luteal phase of menstruation and pregnancy, as 
well as a cessation of contraceptive estrogen agonists 
in young adults [15]. 
Patients with a diagnosis of non-glioma primary 
cerebral tumors found more than glioma tumors and 
tumor metastases. Of all cerebral tumors, including non-
glioma diagnoses, most patients found with meningioma 
according to Table 3. Based on Central Brain Tumor 
Registry of the United States data from 2007 to 2011, it 
noted that meningiomas were the most common tumors 
in more than 35% of all adult primary brain tumors 
followed by glioblastoma (16%). Anindhita and Wiratma 
said that the majority of primary tumors are astrocytoma 
(47%) followed by meningioma (26%) [16]. This only 
illustrates the incidence of patients admitted to intensive 
care, where there may be more glioma or non-glioma 
tumor patients who treated intensively outside.
All tumor patients treated in the intensive 
care unit at Sanglah General Hospital in the period of 
January–December 2017 are patients who undergo 
practical actions, which operated more until the 3rd day 
and came out alive and without complications during 
intensive care. This shows the role of great space in 
post-operative care. To treat other severe complications 
of cerebral tumors, themselves have not been recorded 
in this period.
Conclusion
The most brain tumor cases are meningioma, 
which occurred in women, middle-aged adults with 
no mortality and complications within 3 days during 
treatment intensive care.
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